GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TSH Biopharm Corp Ltd (ROCO:8432) » Definitions » Marketable Securities

TSH Biopharm (ROCO:8432) Marketable Securities : NT$408.5 Mil (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is TSH Biopharm Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. TSH Biopharm's Marketable Securities for the quarter that ended in Mar. 2024 was NT$408.5 Mil.

TSH Biopharm's annual Marketable Securities declined from Dec. 2021 (NT$351.5 Mil) to Dec. 2022 (NT$326.9 Mil) and declined from Dec. 2022 (NT$326.9 Mil) to Dec. 2023 (NT$195.5 Mil).


TSH Biopharm Marketable Securities Historical Data

The historical data trend for TSH Biopharm's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TSH Biopharm Marketable Securities Chart

TSH Biopharm Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 458.39 328.97 351.52 326.86 195.54

TSH Biopharm Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 335.84 188.75 189.21 195.54 408.48

TSH Biopharm Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


TSH Biopharm  (ROCO:8432) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


TSH Biopharm Marketable Securities Related Terms

Thank you for viewing the detailed overview of TSH Biopharm's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


TSH Biopharm (ROCO:8432) Business Description

Traded in Other Exchanges
N/A
Address
No.3-1, Park Street, 3rd Floor-1, Nangang District, Taipei, TWN, 115
TSH Biopharm Corp Ltd is engaged in the sale of a variety of pharmaceuticals, chemical drugs and biotechnology services. The Company's revenue is earned domestically.

TSH Biopharm (ROCO:8432) Headlines

No Headlines